The RWD & RWE Podcast
*** Join our weekly Real-World Wednesdays (RWW) Clubhouse room every Wed @ 11am Eastern US Time*** All things related to the collection, creation & use of Real-World Data (RWD) in generating Real-World Evidence (RWE) for clinical research, drug development, medical devices, value access and other activities for BioPharma and the Life Sciences! Real-World Data (RWD): data relating to a person’s health status or well-being, or the care received by a person, as collected from real-world settings (as opposed to the controlled clinical trial setting) [aka observational data, healthcare data, etc.] Real-World Evidence (RWE): the appropriate analysis of RWD Reliable RWD + Appropriate Analysis = Meaningful RWE
Episodes
![Ep 117 [15 November 2023]: Georges De Feu & Shahbaz Pervaiz – Unlock European RWE](https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_300x300.jpeg)
Nov 15, 2023
Nov 15, 2023
1 hr 1 min
Ep 117 [15 November 2023]: Conversation with Georges De Feu, CEO and co-founder of LynxCare – a European RWD provider is joined by his RWE Services Director – Shahbaz Pervaiz – We discussed the need for NLP-AI to unlock European unstructured data and the enablers for federated networks of hospital.
![Ep 116 [08 November 2023]: Canter Martin MBA – Selecting the Right RWE/RWD Partner](https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_300x300.jpeg)
Nov 11, 2023
Nov 11, 2023
1 hr 54 sec
Ep 116 [08 November 2023]: Conversation with Canter Martin MBA, Executive Leader in Life Science Value & Access and Co-Founder of Elev8Evidence – We discussed the importance of strategic partnerships in the effective use of RWD and generating meaningful RWE -- Best practices in selecting the right partner!
![Ep 115 [01 November 2023]: Carla DeMuro MS – RWD - Are we measuring the right thing?](https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_300x300.jpeg)
Nov 3, 2023
Nov 3, 2023
1 hr 48 sec
Ep 115 [01 November 2023]: Conversation with Carla DeMuro MS, Vice President, Patient-Centered Outcomes Assessment at RTI Health Solutions – We discussed the use of PROs in real-world evidence generation. Are we measuring the right thing?
![Ep 114 [25 October 2023]: Stuart McCully PhD – EU’s RWD Revolution in Health Research & Drug Development](https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_300x300.jpeg)
Nov 3, 2023
Nov 3, 2023
57 min
Ep 114 [25 October 2023]: Conversation with Stuart McCully PhD, CEO of RWRegs – We discussed updates on the EU's advancement and global leadership of RWD for RWE.Shared References:- https://www.linkedin.com/posts/stuart-mccully-80a50aa_31-real-world-evidence-rwe-201-eus-activity-7122884522311835648-bUFD/- https://digital-strategy.ec.europa.eu/en/news/european-strategy-data-data-governance-act-becomes-applicable
![Ep 113 [18 October 2023]: Mark van der Laan PhD – Get real! Targeted Learning: Why is it Important to Data Analysis?](https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_300x300.jpeg)
Oct 19, 2023
Oct 19, 2023
1 hr 2 min
Ep 113 [18 October 2023]: Conversation with Mark van der Laan PhD, Co-Founder at TL Revolution and Jiann-Ping Hsu/Karl E Peace Professor in Biostatistics and Statistics at UC Berkeley – We had a high-level yet thought-provoking discussion on the importance of using Targeted Learning and Machine Learning to support RWD analysis and clinical research.
![Ep 112 [11 October 2023]: Christina Mack PhD – Moment or a movement? Using RWE to impact population health.](https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_300x300.jpeg)
Oct 11, 2023
Oct 11, 2023
1 hr 22 sec
Ep 112 [11 October 2023]: Conversation with Christina Mack PhD, Chief Scientific Officer at IQVIA – She shared highlights from her career journey, her passion for where science can take us in a data-driven world, and stories about how real-world evidence is changing the game in professional sports and global public health.
![Ep 111 - [04 October 2023]: Sylvia Taylor PhD MPH MBA – COVID-19 vaccines and the pivotal role of RWE](https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_300x300.jpeg)
Oct 5, 2023
Oct 5, 2023
1 hr 1 min
Ep 111 [04 October 2023]: Conversation with Sylvia Taylor PhD MPH MBA, Head of Medical Evidence Strategy, Vaccines & Immune Therapies at AstraZeneca, and a trusted epidemiologist and leader in global health and real-world evidence – We discussed COVID-19 vaccines and the pivotal role of real-world evidence on public health decision making during the pandemic: one epidemiologist’s experience, lessons learned, and thoughts on the future.
![Ep 110 [27 September 2023]: Kirk Geale M.Sc PhD – Finding true north: Navigating the Nordic RWD environment](https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_300x300.jpeg)
Sep 28, 2023
Sep 28, 2023
57 min
Ep 110 [27 September 2023]: Conversation with Kirk Geale M.Sc PhD, CEO at Quantify Research – We had an informative discussion on the Nordic real-world data (RWD) landscape and its use cases: small place, high quality big data!

Sep 21, 2023
Sep 21, 2023
57 min
20 September 2023: Conversation with Matt Veatch MBA and Aaron Kamauu MD MS MPH, Real-World Wednesdays (RWW) co-hosts, senior advisors in RWD, RWE, Decentralized Research; and co-founders of Navidence – We discussed our respective journeys, interests & passions in this field.

Sep 17, 2023
Sep 17, 2023
1 hr 1 min
13 September 2023: Conversation with H. Jack West MD MPhil, Medical Oncologist & Clinical Associate Professor at City of Hope and VP of Network Strategy at AccessHope – We had a thought-provoking discussion from clinical point-of-care around the real-world use of medical evidence. Though RWD may not be perfect "in the land of the blind, the one-eyed man is king!"Reference: Clinical Decision Making in the Real World—The Perfect as the Enemy of the Good: https://jamanetwork.com/journals/jamaoncology/fullarticle/2805799



